The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics

Joint Bone Spine

Volumn 78, Issue 4, 2011, Pages 374-377

  Haroon, Muhammad ^a   Adeeb, Fahd ^a   Eltahir, Ahmed ^a   Harney, Sinead ^a  

^a Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

Immunosuppressive agents; Influenza vaccination; Pneumococcal vaccination

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLUENZA VACCINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; PREDNISOLONE;

ADULT; AGE; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BEHCET DISEASE; CHRONIC LUNG DISEASE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OUTPATIENT; PATIENT ATTITUDE; PNEUMOCOCCAL INFECTION; PNEUMOCOCCUS VACCINATION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK FACTOR; SCLERODERMA; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; UTILIZATION REVIEW; VACCINATION;

COHORT STUDIES; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL VACCINES; QUESTIONNAIRES; RHEUMATIC DISEASES; TREATMENT REFUSAL; VACCINATION;

EID: 79960639254     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.10.012     Document Type: Article

References (22)

1. Thomas E., Symmons D.P., Brewster D.H., et al. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20-year follow-up study. J Rheumatol 2003, 30:958-965.
2. Iliopoulos A.G., Tsokos G.C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 1996, 25:318-336.
3. Sneller M.C. Evaluation, treatment, and prophylaxis of infections complicating systemic vasculitis. Curr Opin Rheumatol 1998, 10:38-44.
4. Gluck T. Vaccinate your immunocompromised patients!. Rheumatology 2006, 45:9-10.
5. British Society for Rheumatology. Vaccinations in immunocompromised persons-guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies. London: British Society for Rheumatology; 2002 []. http://www.rheumatology.org.uk/.
6. Snowden N. Immunisation of immunosuppressed patients with rheumatic diseases. Topical reviews. June 2007 number 12. Reports on Rheumatic Diseases (Series 5): Top Rev 2007;12:1 [Arthritis Research Campaign; 2007. ]. http://www.arthritisresearchuk.org/files/6632_07032010181003.pdf.
7. Summary of flu immunisation policy-Department of health. http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Flu.
8. http://www.isr.ie/documents/default.asp%3FNCID=56%26NID=577.
9. Fessler B.J. Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis. Best Pract Res Clin Rheumatol 2002, 16:281-291.
10. Kang I., Park S.H. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 2003, 15:528-534.
11. Franklin J., Lunt M., Bunn D., et al. Risk and predictors of infection leading to hospitalisation in a large primary care-derived cohort of inflammatory polyarthritis. Ann Rheum Dis 2007, 66:308-312.
12. Wolfe F., Caplan L., Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum 2006, 54:628-634.
13. Cohen J., Pinching A.J., Rees A.J., et al. Infection and immunosuppression: a study of the infective complications of 75 patients with immunologically-mediated disease. Q J Med 1982, 51:1-15.
14. Buchsbaum D.G., Buchanan R.G., Lawton M.J., et al. A program of screening and prompting improves short-term physician counseling of dependent and nondependent harmful drinkers. Arch Intern Med 1993, 153:1573-1577.
15. Austin SM, Balas EA, Mitchell JA, et al. Effect of physician reminders on preventive care: meta-analysis of randomized clinical trials. Proc Annu Symp Comput Appl Med Care 1994:121-4.
16. Horwood F., MacFarlane J. Pneumococcal and influenza vaccination: current situation and future prospects. Thorax 2002, 57:ii24-ii30.
17. Sihvonen S., Korpela M., Mustonen J., et al. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids: a population-based cohort study. J Rheumatol 2006, 33:1740-1746.
18. Ruyssen-Witrand A., Fautrel B., Saraux A., et al. Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine 2010, 77:246-251.
19. Van der Veen M.J., van der Heide A., Kruize A.A., et al. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994, 53:224-228.
20. Bernatsky S., Hudson M., Suissa S. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology 2007, 46:1157-1160.
21. Kapetanovic M.C., Saxne T., Sjoholm A., et al. Influence of methotrexate. TNF-blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006, 45:106-111.
22. Kapetanovic M.C., Saxne T., Nilsson J.A., et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2007, 46:608-611.